当前位置:首页 - 行情中心 - 睿智医药(300149) - 财务分析 - 资产负债表

睿智医药

(300149)

  

流通市值:47.41亿  总市值:49.75亿
流通股本:4.75亿   总股本:4.98亿

资产负债表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
流动资产:
  货币资金430,691,722.74411,827,245.14367,898,923.12356,923,854.27
  交易性金融资产33,988,894.445,566,024.8834,089,618.5219,195,359.46
  应收票据及应收账款239,510,100.31229,257,390.3198,077,071.43184,906,219.87
  其中:应收票据--24,48062,056.08
        应收账款239,510,100.31229,257,390.3198,052,591.43184,844,163.79
  应收款项融资21,61521,615--
  预付款项17,027,917.147,913,437.0211,097,583.2111,209,900.4
  其他应收款合计5,236,438.236,907,604.5937,361,718.8540,966,999.76
  存货16,576,124.379,470,383.019,194,027.5514,092,024.22
  合同资产4,197,945.159,017,292.545,730,117.6915,889,411.71
  一年内到期的非流动资产339,520.57344,888.6348,652.11351,257.61
  其他流动资产41,273,070.8444,691,512.0233,666,717.3336,882,062.47
  流动资产合计788,863,348.75765,017,393.1697,464,429.81680,417,089.77
非流动资产:
  长期股权投资173,529,958.08175,512,693.55166,119,760.83166,142,961.72
  其他权益工具投资16,000,00010,000,00010,000,00010,000,000
  投资性房地产73,461,882.4373,384,129.473,134,911.4974,095,284.36
  固定资产306,483,752311,781,702.4306,026,410.46313,757,012.48
  在建工程8,717,755.174,071,000.287,378,751.037,143,820.59
  使用权资产285,260,244.25301,595,932.73323,203,933.48315,281,167.71
  无形资产32,898,658.7232,694,691.834,217,617.732,749,673.94
  长期待摊费用227,275,893.72238,126,764.62244,999,309.46253,947,931.33
  递延所得税资产52,416,082.8746,753,425.8241,151,007.2741,804,277.35
  其他非流动资产75,133,481.9574,007,465.5185,757,434.1585,247,638.95
  非流动资产合计1,251,177,709.191,267,927,806.111,291,989,135.871,300,169,768.43
  资产总计2,040,041,057.942,032,945,199.211,989,453,565.681,980,586,858.2
流动负债:
  短期借款67,400,00067,315,888.8950,308,611.1156,317,222.22
  应付票据及应付账款58,745,199.5950,309,326.0848,687,203.2250,283,298.94
  其中:应付票据---0
        应付账款58,745,199.5950,309,326.0848,687,203.2250,283,298.94
  合同负债41,302,701.2645,278,800.142,370,457.8145,199,630.76
  应付职工薪酬50,689,948.8648,919,772.3340,494,602.6531,936,583.24
  应交税费7,474,912.556,536,881.046,408,877.57,417,036.43
  其他应付款合计76,535,729.5768,159,517.9974,550,120.6382,059,383.47
  一年内到期的非流动负债66,516,668.6767,906,886.2569,386,246.4469,743,922.07
  其他流动负债945,420.981,018,157.18528,852.19461,428.65
  流动负债合计369,610,581.48355,445,229.86332,734,971.55343,418,505.78
非流动负债:
  长期借款28,874,91628,919,206.3233,014,91633,014,916
  租赁负债288,305,329.44305,029,345.91311,956,854.47306,366,167.67
  长期应付款2,645,097.132,869,050.94--
  预计负债13,636,177.9613,568,199.285,648,422.025,588,612.85
  递延收益22,263,303.9623,457,450.124,889,143.926,337,660.18
  递延所得税负债3,259,182.473,297,186.073,379,970.183,580,645.63
  非流动负债合计358,984,006.96377,140,438.62378,889,306.57374,888,002.33
  负债合计728,594,588.44732,585,668.48711,624,278.12718,306,508.11
所有者权益(或股东权益):
  实收资本(或股本)497,963,992497,963,992497,963,992497,963,992
  资本公积1,288,314,354.51,259,574,3961,240,375,403.041,204,738,551.03
  其他综合收益11,539,746.0615,988,741.4119,046,065.8620,950,670.82
  盈余公积169,649,539.17169,649,539.17169,651,962.19169,651,962.19
  未分配利润-685,316,021.05-667,159,552.55-673,480,411.91-655,189,594.74
  归属于母公司股东权益合计1,282,151,610.681,276,017,116.031,253,557,011.181,238,115,581.3
  少数股东权益29,294,858.8224,342,414.724,272,276.3824,164,768.79
  股东权益合计1,311,446,469.51,300,359,530.731,277,829,287.561,262,280,350.09
  负债和股东权益合计2,040,041,057.942,032,945,199.211,989,453,565.681,980,586,858.2
公告日期2026-04-292026-04-292025-10-302025-08-29
审计意见(境内)标准无保留意见
TOP↑